Related references
Note: Only part of the references are listed.Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer
Mateja Condic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
N-6-Methyladenosine (m(6)A) readers are dysregulated in renal cell carcinoma
Felix von Hagen et al.
MOLECULAR CARCINOGENESIS (2021)
The N6-methyladenosine (m6A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity-associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinoma
Alexander Strick et al.
BJU INTERNATIONAL (2020)
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang et al.
CANCER CELL (2020)
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma
Yuanyuan Ban et al.
MOLECULAR ONCOLOGY (2020)
METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma
Lin Liu et al.
MOLECULAR THERAPY (2020)
N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
Qianqing Wang et al.
CELL DEATH & DISEASE (2020)
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
Jiangfeng Li et al.
MOLECULAR CANCER (2020)
N6-Methyladenosine and Viral Infection
Wei Dang et al.
FRONTIERS IN MICROBIOLOGY (2019)
Association of N6-methyladenosine with viruses and related diseases
Fang Wu et al.
VIROLOGY JOURNAL (2019)
Knockdown of METTL14 inhibits the growth and invasion of cervical cancer
Feng Geng et al.
TRANSLATIONAL CANCER RESEARCH (2019)
The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells
Dongling Zou et al.
CANCER CELL INTERNATIONAL (2019)
FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting -catenin through mRNA demethylation
Shun Zhou et al.
MOLECULAR CARCINOGENESIS (2018)
N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herpesvirus infection
Charles R. Hesser et al.
PLOS PATHOGENS (2018)
Addition of m6 A to SV40 late mRNAs enhances viral structural gene expression and replication
Kevin Tsai et al.
PLOS PATHOGENS (2018)
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
Jun Liu et al.
NATURE CELL BIOLOGY (2018)
Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis
Jianxin Zhang et al.
PLOS ONE (2018)
Vulvar cancer in high-income countries: Increasing burden of disease
Yoon-Jung Kang et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
Ly P. Vu et al.
NATURE MEDICINE (2017)
Detecting RNA modifications in the epitranscriptome: predict and validate
Mark Helm et al.
NATURE REVIEWS GENETICS (2017)
Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology
Thomas Hecking et al.
ONCOTARGET (2017)
The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy
A. A. Clancy et al.
ANNALS OF ONCOLOGY (2016)
Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma
Maaike C. G. Bleeker et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Risk factors and treatment for recurrent vulvar squamous cell carcinoma
L. S. Nooij et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015
H. G. Schnuerch et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2016)
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Martyn Plummer et al.
LANCET GLOBAL HEALTH (2016)
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Harrell W. Chesson et al.
SEXUALLY TRANSMITTED DISEASES (2014)
Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma
M. S. Schuurman et al.
EUROPEAN JOURNAL OF CANCER (2013)
The birth of the Epitranscriptome: deciphering the function of RNA modifications
Yogesh Saletore et al.
GENOME BIOLOGY (2012)
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States
Ralph P. Insinga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Trends in the incidence of invasive and in situ vulvar carcinoma
Patricia L. Judson et al.
OBSTETRICS AND GYNECOLOGY (2006)
Molecular biology of human papillomavirus infection and cervical cancer
John Doorbar
CLINICAL SCIENCE (2006)
Worldwide burden of gynaecological cancer: The size of the problem
R Sankaranarayanan et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2006)
Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways
IAM van der Avoort et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)
Share Paper
